Neurological presentations of a secondary antiphospholipid syndrome

Abstract

The aim of the study is to turn the attention of specialists to antiphospholipid syndrome (APS), which is of interest to physicians of many specialties. The observation of the patient W., 32 years, with secondary APS was analyzed. Poor prognostic factors in CFA are the high frequency of thrombotic complications and thrombocytopenia, and laboratory markers — the presence of lupus anticoagulant. All patients with APS should be under medical supervision, whose main task is to assess the risk of recurrence of venous or arterial thrombosis and its prevention.

Keywords

• 32-glycoprotein I
• antiphospholipid syndrome
• epileptic seizures
• lupus anticoagulant
• venous thrombosis